Dietary strategies for glycogen storage disease type I
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests different diet strategies to help adults with GSDI (a metabolic condition also known as von Gierke disease) maintain stable blood sugars and avoid dangerous drops. It may help you learn how to better manage your condition through diet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glycogen storage disease type I (GSDIa or GSDIb).
- You are 18 years or older.
- You already limit fructose in your daily diet as part of your treatment.
- You are willing and able to give written consent to take part.
- You have not had a liver transplant and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a carbohydrate counting method helps children with glycogen storage disease type 1 (GSD1) better manage their blood sugar, improve quality of life, and affect certain biomarkers. It may help families learn a new way to plan meals and stabilize glucose levels.
This study uses a glucose monitor (a small sensor you wear) to measure how your blood sugar responds after eating raw cornstarch, a common treatment for glycogen storage disease type I. The goal is to understand how well cornstarch helps keep your blood sugar steady.
This trial tests whether a medicine called diazoxide can help treat type 1 glycogenosis, a rare metabolic condition that affects how the body stores and uses sugar. Participation is limited to patients already being followed at one of two French hospitals.
This study tests how well a home lactate meter and a standard blood sugar meter work for people with certain types of Glycogen Storage Disease (GSD Ia, Ib, or XI). If you or your child has one of these types, joining could help improve home monitoring.
This study tests an experimental medicine called BEAM-301 for people with a specific form of glycogen storage disease type Ia (GSDIa). The goal is to see if it can help reduce dangerous low blood sugar episodes.
This trial tests whether taking fucose (a type of sugar) can help people with GLUT1 deficiency syndrome, a rare genetic condition that affects how the brain gets energy. If you have ataxia (trouble with balance or coordination) and meet other criteria, this study may be an option for you.
Hear when a new Glycogen Storage Disease Type I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.